FormWeb • methenamine mandelate-sodium acid phosphate

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

Uroqid-Acid No.2

methenamine mandelate-sodium acid phosphate

Restricted Uroquid-Acid No. 2 --> restricted to NO SUB orders.
Therapeutic Interchange Methenamine Urinary Combinations Formulary

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Uroqid-Acid No.2	TABLET, ORAL	500 mg- 500 mg

Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

methenamine mandelate-sodium acid phosphate (Uroqid-Acid No. 2)

500 mg-500 mg tablet oral QID
TWO 500 mg-500 mg tablets (Total: 1,000 mg-1,000 mg) QID

methenamine mandelate (Mandelamine)

500 mg tablet QID
TWO 500 mg tablet (Total: 1,000 mg) QID

Last updated: Jun. 16, 2016

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.